Paula Grasberger

735 total citations
10 papers, 350 citations indexed

About

Paula Grasberger is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Virology. According to data from OpenAlex, Paula Grasberger has authored 10 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Virology. Recurrent topics in Paula Grasberger's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), HIV Research and Treatment (2 papers) and DNA Repair Mechanisms (2 papers). Paula Grasberger is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), HIV Research and Treatment (2 papers) and DNA Repair Mechanisms (2 papers). Paula Grasberger collaborates with scholars based in United States, Japan and Mexico. Paula Grasberger's co-authors include Andrew M. Tager, Clemens K. Probst, David Lagares, Norihiko Sakai, Jeremy Ryan, Daniel J. Tschumperlin, Patrick Bhola, Anthony Letai, Fei Liu and Joan Montero and has published in prestigious journals such as Cancer Research, Science Translational Medicine and European Journal of Cancer.

In The Last Decade

Paula Grasberger

9 papers receiving 346 citations

Peers

Paula Grasberger
Iyabode O. Ajayi United States
Deanna Diebold United States
Brittani Agostini United States
Julie C. Worrell United Kingdom
Harold P. Gaetz United States
Iyabode O. Ajayi United States
Paula Grasberger
Citations per year, relative to Paula Grasberger Paula Grasberger (= 1×) peers Iyabode O. Ajayi

Countries citing papers authored by Paula Grasberger

Since Specialization
Citations

This map shows the geographic impact of Paula Grasberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Grasberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Grasberger more than expected).

Fields of papers citing papers by Paula Grasberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Grasberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Grasberger. The network helps show where Paula Grasberger may publish in the future.

Co-authorship network of co-authors of Paula Grasberger

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Grasberger. A scholar is included among the top collaborators of Paula Grasberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Grasberger. Paula Grasberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grasberger, Paula & Kiera Clayton. (2025). Targeting HIV myeloid and central nervous system reservoirs for HIV cure. Current Opinion in HIV and AIDS. 20(6). 526–532.
2.
Grasberger, Paula, et al.. (2024). Harnessing immune cells to eliminate HIV reservoirs. Current Opinion in HIV and AIDS. 19(2). 62–68. 2 indexed citations
3.
Shenker, Sol, Hugh Gannon, Paula Grasberger, et al.. (2021). Abstract 1337: Functional genomic characterization of the USP1 inhibitor KSQ-4279 reveals a distinct mechanism of action and resistance profile relative to other DDR targeting drugs. Cancer Research. 81(13_Supplement). 1337–1337. 7 indexed citations
4.
Santos, Daniela M., Lorena Pantano, Paula Grasberger, et al.. (2020). Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(4). 479–492. 47 indexed citations
5.
Sullivan, Richard, Sol Shenker, Michael McGuire, et al.. (2020). Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. European Journal of Cancer. 138. S52–S52. 15 indexed citations
6.
Lagares, David, Paula Grasberger, Fei Liu, et al.. (2017). Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. Science Translational Medicine. 9(420). 161 indexed citations
7.
Knipe, Rachel S., Clemens K. Probst, David Lagares, et al.. (2017). The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 58(4). 471–481. 88 indexed citations
8.
Lagares, David, Paula Grasberger, Adam J. Engler, & Andrew M. Tager. (2016). Targeting fibroblast durotaxis as novel anti-fibrotic therapy for IPF. QJM. 1 indexed citations
9.
Wurcel, Alysse G., et al.. (2016). Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis Screening. Open Forum Infectious Diseases. 3(1). ofv215–ofv215. 6 indexed citations
10.
Ahluwalia, Neil, Paula Grasberger, Carol Feghali‐Bostwick, et al.. (2015). Fibrogenic Lung Injury Induces Non–Cell-Autonomous Fibroblast Invasion. American Journal of Respiratory Cell and Molecular Biology. 54(6). 831–842. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026